Sofgen Pharmaceuticals, part of Procaps Group, is an integrated Softgel CDMO that offers end-to-end solutions in Softgel technologies from development through delivery for prescription drugs, OTC products, and specialized nutraceuticals for pharmaceutical companies looking for differentiation, while simultaneously improving efficiency, and gaining access to specialized expertise, and unique technologies for their products.
Scroll down »

To Provide an unparalleled experience with reliable development manufacturing services and niche proprietary products, innovation in technologies, contributing to health and well-being of consumers and patients in key markets.


Driven by our passion to offer positive experiences across each customer touchpoint. We mix our deep softgel knowledge and expertise, our flexibility, our desire to develop customized products that exceed customers’ expectation, mixed with a relationship based on connectivity, trust and empathy.

Leaders in the Development & Manufaturing of pharmaceutical solution in the HRM market for 20* years.        Leaders in the Development & Manufaturing of pharmaceutical solution in the HRM market for 20* years.

Our Softgel facility and Center for Pharmaceutical Excellence located in West Palm Beach, US, specializes in the development and manufacturing of high-end softgel technologies, with expertise in differentiated manufacturing technologies, hormonal products, high potency compounds and other complex oral modalities.
We offer a diverse service portfolio that goes from research for advanced delivery technologies, end-to-end solutions for orphan / fast-track developments, pre-clinical and clinical developments for New Molecular Entities, drug product tech-transfers, Lab analytical services, packaging & product inspection services. 
At CPhE we have proven expertise in:
Developer and manufacturer of innovative oral Pharmaceutical solutions around the Soft Gelatin Capsule format.
Procaps Group, S.A. ("Procaps Group") (NASDAQ: PROC) is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 4,900 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.
For more information, visit Procaps Group or Procaps Group’s investor relations website.
Schedule a tour and visit our Center for Pharmaceutical Excellence